MoIDX Open Meeting: October 6, 2025

Published 03/06/2026

Open Meeting Notification — Proposed LCD(s) Released for Comment 

  1. MolDX: Genetic Testing for Hereditary Thrombophilia DL40238
     
  2. MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer DL40210
     
  3. MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis DL40187

The Centers for Medicare & Medicaid Services (CMS) assigned Palmetto GBA the task of developing local coverage determinations (LCDs) for processing and reviewing Medicare claims for Jurisdictions J and M. These LCDs can be found utilizing the Proposed LCD by Contractor Report on the Medicare Coverage Database. The entire LCD and related billing and coding article should be completely reviewed prior to the preparation of comments. 

Palmetto GBA solicited comments on these proposed LCDs from physicians, manufacturers, suppliers and other professionals involved in the ordering and/or provisioning of these items. Other stakeholder comments are also welcomed.

Meeting Materials


Was this article helpful?